Regenxbio (RGNX) Gross Margin (2014 - 2024)
Regenxbio (RGNX) recorded quarterly Gross Margin of 70.22% in Q4 2024, up 43.87% quarter-over-quarter from 48.81% in Q3 2024, and up 2081.0% on a YoY basis from 3.22% in Q1 2024.
Regenxbio (RGNX) Gross Margin (2014 - 2024) Analysis & Trends
Regenxbio's Gross Margin history runs 11 years deep, the most recent figure standing at 70.22% for Q4 2024.
- In Q4 2024, Gross Margin rose 2081.0% year-over-year to 70.22%; the TTM figure through Dec 2024 stood at 59.72% (up 95.0% YoY), while the FY2024 annual figure was 59.72%, up 95.0% from the prior year.
- Gross Margin was 70.22% for Q4 2024 at Regenxbio, up from 48.81% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 94.22% in Q4 2021 to a low of 29.26% in Q1 2022.
- Historically, Gross Margin has averaged 62.32% across 5 years, with a median of 58.19% in 2022.
- The sharpest annual moves came in 2022 and 2023: Gross Margin plunged 4505 bps in 2022, then jumped 4925 bps in 2023.
- A 5-year view of Gross Margin shows it stood at 52.17% in 2020, then jumped by 81 bps to 94.22% in 2021, then sank by 37 bps to 59.22% in 2022, then retreated by 17 bps to 49.41% in 2023, then surged by 42 bps to 70.22% in 2024.
- The last three Gross Margin figures came in at 70.22% (Q4 2024), 48.81% (Q3 2024), and 52.55% (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 79.04% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 86.85% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Regenxbio | 315.11 Mn | 85.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 70.22% |
| Sep 30, 2024 | 48.81% |
| Jun 30, 2024 | 52.55% |
| Mar 31, 2024 | 72.58% |
| Dec 31, 2023 | 49.41% |
| Sep 30, 2023 | 57.16% |
| Jun 30, 2023 | 52.57% |
| Mar 31, 2023 | 78.51% |
| Dec 31, 2022 | 59.22% |
| Sep 30, 2022 | 50.61% |
| Jun 30, 2022 | 60.33% |
| Mar 31, 2022 | 29.26% |
| Dec 31, 2021 | 94.22% |
| Sep 30, 2021 | 54.16% |
| Jun 30, 2021 | 55.44% |
| Mar 31, 2021 | 74.31% |
| Dec 31, 2020 | 52.17% |
| Sep 30, 2020 | 82.45% |
| Jun 30, 2020 | 71.73% |
| Mar 31, 2020 | 80.68% |